Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial

Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M; Diehl, V; Engert, A; Borchmann, P (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of oncology, 23(7), pp. 1818-25. Oxford: Oxford University Press 10.1093/annonc/mdr575

[img]
Preview
Text
mdr575.pdf - Published Version
Available under License Publisher holds Copyright.

Download (261kB) | Preview

In the HD14 trial, 2×BEACOPPescalated+2×ABVD (2+2) has improved the primary outcome. Compared with 4×ABVD, this benefit might be compromised by more infertility in women. Therefore, we analyzed gonadal function and fertility.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

von Wolff, Michael

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:40

Last Modified:

23 Oct 2019 04:16

Publisher DOI:

10.1093/annonc/mdr575

PubMed ID:

22228451

Web of Science ID:

000306135200026

BORIS DOI:

10.7892/boris.16471

URI:

https://boris.unibe.ch/id/eprint/16471 (FactScience: 224121)

Actions (login required)

Edit item Edit item
Provide Feedback